Ground News

institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

ajmc.com image

News from ajmc.com

See all of ajmc.com news coverage in one place. Discover how ajmc.com’s media bias informs their coverage and compare with thousands of other news outlets.

We’ve aggregated 956 of ajmc.com’s headlines and news stories over the past 3 months.

ajmc.com’s aggregated media bias check is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

ajmc.com’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about ajmc.com

Where is ajmc.com located?ajmc.com's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top ajmc.com News

Major Insurance Changes Are Coming for Weight Loss Drugs. Here’s How It Could Affect Patients

Major Insurance Changes Are Coming for Weight Loss Drugs. Here’s How It Could Affect Patients

84% Center coverage: 32 sources

Major insurance changes are coming to GLP-1 drugs for weight loss. Here’s what to know See the Story

Anti-Abortion Leader Argues US Was Not Ready for Roe or Dobbs Decisions

Jennifer Evans · United States

Anti-Abortion Leader Argues US Was Not Ready for Roe or Dobbs Decisions

75% Left coverage: 8 sources

Americans United for Life has written model legislation that called for "Defunding Abortion," targeting organizations including Planned Parenthood that also provides reproductive health care services including birth controls, STI testing and other screening. (Photo by Olivier Douliery/Getty Images)Despite heading one of the oldest anti-abortion organizations in the country at a time of huge upheaval for abortion rights, John Mize is new to the m…See the Story

New Bispecific T-Cell Engager Approved for Multiple Myeloma

Cancer · United States

New Bispecific T-Cell Engager Approved for Multiple Myeloma

83% Center coverage: 6 sources

(MedPage Today) -- The FDA on Wednesday granted accelerated approval to linvoseltamab (Lynozyfic) for relapsed or refractory multiple myeloma after at least four prior lines of therapy. A B-cell maturation antigen (BCMA)-directed bispecific antibody...See the Story

Blindspots

Anti-Abortion Leader Argues US Was Not Ready for Roe or Dobbs Decisions

The Supreme Court upholds free preventive care, but its future now rests in RFK Jr.’s hands

100% Center coverage: 4 sources

On June 26, 2025, the U.S. Supreme Court handed down a 6-3 ruling that preserves free preventive care under the Affordable Care Act, a popular benefit that helps approximately 150 million Americans stay healthy. Robert F. Kennedy Jr. · United States See the Story

Black Patients Less Likely to Receive Treatment Referrals After Opioid Overdose

83% Left coverage: 6 sources

(MedPage Today) -- Referrals for outpatient treatment after a suspected opioid overdose ranged from 8% to 44%, and Black patients were less likely to receive such a referral versus white patients, according to a secondary analysis of a prospective...United States · United States See the Story

Analysis Supports Flexible Axatilimab Use in Chronic GVHD, Calls for Combination Therapy Research: Carrie Kitko, MD

Carrie Kitko, MD, explains that axatilimab maintains strong response rates in patients with chronic graft-versus-host disease (GVHD) regardless of previous treatment lines and emphasizes the need to explore combination therapies.Maryland · Maryland Read Article

Educating on Menin Inhibitors

Panelists emphasize that effective use of menin inhibitors for KMT2A-rearranged acute myeloid leukemia (AML) requires dispelling common misconceptions about oral targeted therapy, ensuring close monitoring for adverse effects, clarifying treatment goals—especially the role of transplant—and supporting patients through comprehensive education and multidisciplinary care.Read Article

Overcoming Weight Bias in Clinical Practice

Panelists discuss how unconscious bias and weight stigma create barriers to care, requiring providers to acknowledge their own biases, create welcoming clinical environments with appropriate accommodations, and approach patients with compassion rather than judgment about willpower.Read Article

Mirdametinib as a Therapy for Patients With NF1-PN

Panelists discuss how mirdametinib's oral administration offers convenience and improves compliance, especially in pediatric patients, and how its ability to stabilize progressive, symptomatic NF1-associated plexiform neurofibromas without the need for invasive procedures fills a critical gap in treatment options while also addressing potential access barriers related to insurance coverage and cost.Read Article

The Double-Edged Sword of Artificial Sweeteners

The market for artificial sweeteners has been projected to increase by almost 75% from 2025 through 2033, or from $3.11 billion to $5.44 billion.Read Article

Emerging Menin Inhibitors and Patient Impact

Panelists highlight that the emergence of menin inhibitors is reshaping the treatment paradigm for KMT2A-rearranged acute myeloid leukemia (AML), with ongoing research focused on optimizing their use, overcoming resistance, expanding access, and integrating these targeted therapies into personalized and potentially curative treatment strategies across diverse patient populations.Read Article

Breaking News Topics Related to ajmc.com